Covid19, SARS-CoV-2
Conditions
Keywords
Screening, asymptomatic
Brief summary
The proportion of asymptomatic carriers of SARS-CoV-2 remains elusive, so the potential benefit of systematic screening during the SARS-CoV-2-pandemic is controversial. We investigate the proportion of asymptomatic inpatients who were identified by systematic screening for SARS-CoV-2 upon hospital admission. Adult patients admitted to the University Hospital Basel from 01.04.-14.06.2020 were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs. Each patient screened during the study period was retrospectively classified symptomatic or asymptomatic for COVID-19 based on medical chart review.
Interventions
DIAGNOSTIC_TESTTesting for SARS-CoV-2
All Patients admitted to the hospital were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs.
Sponsors
University Hospital, Basel, Switzerland
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* The patient population is defined as all adult patients hospitalized in the University Hospital Basel from April 1st, 2020 to June 14th, 2020.
Exclusion criteria
* Outpatients * Patients with SARS-CoV-2 screening in the outpatient test center * Patients with a SARS-CoV-2 test more than 72 hours before hospital admission * Test not performed (for any reason)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of SARS-CoV-2 -infected patients | 01.04.2020-14.06.2020 | We aim to determine the proportion of SARS-CoV-2-infected patients detected by systematic at-admission screening |
Countries
Switzerland
Outcome results
None listed